Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atkins

Showing results (431-440 of 514) with videos related to

Pageof 52
Sort By:
International Journal of Oncology|August 9, 2001
Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of boneA Evdokiou, G J Atkins, S Bouralexis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 2021
Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male miceYolandi Starczak, Daniel C Reinke, Kate R Barratt, et al.
JBMR Plus|September 17, 2021
Differential Iron Requirements for Osteoblast and Adipocyte DifferentiationDaniel F Edwards, Christopher J Miller, Arelis Quintana-Martinez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2011
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismGerald J Atkins, Peter S Rowe, Hui P Lim, et al.
Journal of Clinical Medicine|January 11, 2022
Long-Term Outcomes of Staged Revision Surgery for Chronic Periprosthetic Joint Infection of Total Hip ArthroplastyChristopher W Day, Kerry Costi, Susan Pannach, et al.
Cancer Research|September 23, 2003
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivoAmanda N Farrugia, Gerald J Atkins, L Bik To, et al.
Investigative Ophthalmology & Visual Science|October 25, 2012
Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κBErin F Gillespie, Nupur Raychaudhuri, Konstantinos I Papageorgiou, et al.
Bone|March 31, 2007
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3Gerald J Atkins, Paul H Anderson, David M Findlay, et al.
European Cells & Materials|October 8, 2021
Evidence for osteocyte-mediated bone-matrix degradation associated with periprosthetic joint infection (PJI)R T Ormsby, A R Zelmer, D Yang, et al.
Bone|May 5, 2001
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of boneG J Atkins, S Bouralexis, D R Haynes, et al.
Pageof 52

Showing results (431-440 of 514) with videos related to

Sort By:
Pageof 52
International Journal of Oncology|August 9, 2001
Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of boneA Evdokiou, G J Atkins, S Bouralexis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 2021
Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male miceYolandi Starczak, Daniel C Reinke, Kate R Barratt, et al.
JBMR Plus|September 17, 2021
Differential Iron Requirements for Osteoblast and Adipocyte DifferentiationDaniel F Edwards, Christopher J Miller, Arelis Quintana-Martinez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2011
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismGerald J Atkins, Peter S Rowe, Hui P Lim, et al.
Journal of Clinical Medicine|January 11, 2022
Long-Term Outcomes of Staged Revision Surgery for Chronic Periprosthetic Joint Infection of Total Hip ArthroplastyChristopher W Day, Kerry Costi, Susan Pannach, et al.
Cancer Research|September 23, 2003
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivoAmanda N Farrugia, Gerald J Atkins, L Bik To, et al.
Investigative Ophthalmology & Visual Science|October 25, 2012
Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κBErin F Gillespie, Nupur Raychaudhuri, Konstantinos I Papageorgiou, et al.
Bone|March 31, 2007
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3Gerald J Atkins, Paul H Anderson, David M Findlay, et al.
European Cells & Materials|October 8, 2021
Evidence for osteocyte-mediated bone-matrix degradation associated with periprosthetic joint infection (PJI)R T Ormsby, A R Zelmer, D Yang, et al.
Bone|May 5, 2001
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of boneG J Atkins, S Bouralexis, D R Haynes, et al.
Pageof 52